Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.
Ottawa biotech firm predicts revenues will top $200 million this year – and only rise from there.
Chief executive Roger Eacock says rapid COVID-19 tests are poised to make local biotech company a force on the 'international stage.'
Ottawa biotech firm voluntarily recalled test in May after federal regulatory agency expressed concern about its effectiveness.
The backstory behind the Ottawa biotech company making global headlines for its innovative DNA testing product.
An Ottawa-based biotech firm says Health Canada has given it the go-ahead to start shipping its rapid COVID-19 testing technology.
An Ottawa-based biotech firm says orders are pouring in from across the world for its handheld device that’s designed to produce COVID-19 test results in as little as half an hour
With the COVID-19 crisis becoming more urgent by the day, the Ottawa-based biotech firm says it’s aiming to have a portable test ready 'within weeks'
Local economic development agencies are doing their best to help give the city’s fledgling biotech and medical devices sector a leg up
Finding investors willing to play the long game can be a challenge